Growth ExpectationsLeqembi's future sales guidance is below consensus expectations, indicating lower anticipated growth.
Market ConcernsThe stock has experienced a significant pullback, decreasing by 21% this year and around 50% since its 52-week high, due to investor concerns over competitive pressures.
Product SalesThe disappointing news was the US Skyclarys and US Leqembi sales ramps remain subdued.